Respiratory Infections in Children
8
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship
Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners
Improving Antibiotic Stewardship for Children With Respiratory Illness Presenting to Village Health Workers in Uganda
Priming of the NEonatal Immune System by Transfer of Maternal Immunity
Infant Formula and Toddler Drink Feeding Intervention
Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat
Probiotics, Respiratory and Intestinal Microbiome and Respiratory Tract Infections in Children